Can proton pump inhibitors (PPIs) cause constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can PPIs Cause Constipation?

Yes, PPIs can cause constipation as part of a broader spectrum of bowel symptoms, though the evidence suggests they more commonly cause diarrhea and bloating rather than constipation specifically.

The Evidence on PPI-Related Bowel Symptoms

The most relevant research directly addressing this question found that 92.3% of PPI users reported gastrointestinal symptoms, including abnormal bowel habits in 90% of patients 1. However, the pattern of constipation versus diarrhea depends critically on timing:

  • Constipation predominated (63.8%) in patients who had symptoms BEFORE starting PPIs
  • Diarrhea predominated (56.5%) in patients who developed symptoms AFTER starting PPIs 1

This suggests that while constipation can occur in PPI users, it's more likely a pre-existing condition rather than a direct PPI side effect. When PPIs do cause new bowel symptoms, diarrhea and bloating are more typical.

Mechanism: Small Intestinal Bacterial Overgrowth (SIBO)

The bowel symptoms associated with PPIs appear related to small intestinal bacterial overgrowth (SIBO) or dysbiosis caused by acid suppression 1. The fact that antibiotics (particularly rifaximin) produced the greatest treatment satisfaction for PPI-related bowel symptoms supports this bacterial mechanism 1.

Clinical Context from Guidelines

The 2022 AGA guidelines on PPI de-prescribing mention potential adverse effects of long-term PPI use, including community-acquired pneumonia, hip fracture, and Clostridium difficile infection, but do not specifically list constipation as a recognized adverse effect 2. This omission from major guidelines suggests constipation is not a well-established direct side effect.

Important Clinical Nuance

One study found that relieving constipation actually improved PPI-refractory chest pain in patients with functional bowel disorders 3. Additionally, pre-dinner PPI administration was shown to decrease constipation syndrome in connective tissue disease patients 4. These findings suggest PPIs may sometimes help rather than cause constipation in certain contexts.

Bottom Line for Clinical Practice

  • If a patient on PPIs reports constipation, consider whether it pre-dated PPI therapy
  • New-onset bowel symptoms after starting PPIs more commonly manifest as diarrhea and bloating
  • If constipation is truly PPI-related, it likely represents part of a SIBO/dysbiosis picture rather than a direct drug effect
  • Consider evaluating for other causes of constipation before attributing it to the PPI
  • If PPI-related bowel symptoms are suspected and there's no clear ongoing indication for the PPI, consider de-prescribing per AGA guidelines 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.